An overview of the significance of troponin in acute myocardial infarction

Review

  • Ahmet YALÇINKAYA, [MD] Hacettepe University, Faculty of Medicine Department of Medical Biochemistry
  • Yeşim ÖZTAŞ, [MD, PhD] Hacettepe University, Faculty of Medicine, Department of Medical Biochemistry

Abstract

Biomarkers are helpful tests for making a diagnosis. They are usually the golden standard for their respective diseases. Cardiology, especially, uses biomarkers extensively. Because a great margin of cardiologic emergencies present with a risk of mortality; swift diagnosis and treatment is essential. Biomarkers are helpful in the manner that they shorten diagnosis time. Acute Myocardial Infarction (AMI) is one of the most frequent cardiological emergencies. When it is taken into account that AMI presents with vital risk and that the outcome is dependent on swift diagnosis and treatment speed; it is obvious that it is of utmost importance to have a biomarker that defines the diagnosis with certainty. Cardiac troponin harbors these qualities and is accepted as the fundamental factor for diagnosis and prognosis. This review summarizes the start of biomarker research for AMI until the discovery of troponin, emphasizes troponin’s usage today and provides possible ideas for future enhancement.

Key words: myocardial infarction. cardiac biomarker, troponin, cTnI, cTnT

Downloads

Download data is not yet available.
Published
Nov 6, 2017
How to Cite
YALÇINKAYA, Ahmet; ÖZTAŞ, Yeşim. An overview of the significance of troponin in acute myocardial infarction. Acta Medica, [S.l.], v. 46, n. 1, p. 15-20, nov. 2017. ISSN 2147-9488. Available at: <https://actamedica.org/index.php/actamedica/article/view/107>. Date accessed: 18 nov. 2017.
Section
Review